Company Overview and News

1
M / Macy's, Inc. FORM 144 - ELISA D. GARCIA

8h sec.gov
UNITED STATES UNITED STATES
M

1
M / Macy's, Inc. FORM 144 - ELISA D. GARCIA

8h sec.gov
UNITED STATES UNITED STATES
M

5
Will Retailers Raise Toast to Great Holiday Sales This Year?

2018-09-20 zacks
Retailers count days until the holiday season as eagerly as shoppers look out for eye-popping bargains. No wonder the season, which accounts for a sizeable chunk of yearly revenues and profits, is a make or break time for retailers. With only a couple of months left for the festivities to begin, retail bellwethers from Amazon (AMZN - Free Report) to Walmart (WMT - Free Report) are sure pulling up socks to make a haul this upcoming season.
TGT M LB WMT

6
Bear of the Day: L Brands (LB)

2018-09-20 zacks
L Brands, Inc. (LB - Free Report) continues to struggle as its brands are off trend. This Zacks Rank #5 (Strong Sell) is near 5-year lows. L Brands operates 3,084 stores in the United States, Canada, the United Kingdom and Greater China. Its brands include Victoria's Secret, PINK, Bath & Body Works, La Senza and Henri Bendel. It also operates e-commerce sites for most of those brands and has 800 additional franchised locations worldwide.
MDPEB AEO M LB MDP

65
This Is Why the S&P 500 Will Rally Big Into the End of 2018

2018-09-19 investorplace - 1
The stock market has been on an epic run. Since the 2008 Recession, the S&P 500 has gone on its longest bull run ever and has risen by more than 300% during that stretch.
HD FB SQ SHOP M NFLX GOOG NVDA CRM WMT ADBE TGT JWN AMZN GOOGL AAPL AAXN

16
Why Tilray Stock Is Bound to Fall Hard Sooner or Later

2018-09-19 investorplace - 3
In late July, cannabis company Tilray (NASDAQ:TLRY) went public at $17 per share. Today, exactly two months after its IPO, Tilray stock crossed above $200 and is showing no signs of slowing. As of this writing, stock in Tilray is closing in on $240.
STZ.B JWN BUD WEED M STZ CGC TLRY

3
Investing In A Hated Sector - 13.6% Yield

2018-09-19 seekingalpha
Retail space is overbuilt and the e-commerce is stealing market share - a perfect combo for a disappear to happen.
DDS FB NFLX M

17
It's Not All Negative News - Cramer's Mad Money (9/18/18)

2018-09-19 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday, September 18.
SPLK FB SQ M ADSK TLRY ADBE

6
3 Big Stock Charts for Tuesday: Fortive, General Mills and Macy’s

2018-09-19 investorplace
Faced with the reality that the tariff war might not be ending so soon after all, traders unwound a pretty good chunk of last week’s stock gains on Monday. The S&P 500 pulled back to the tune of 0.56%, ending the session at 2,888.80.
GIS FTV AAPL M NFLX

4
The Tesla of China & the Facebook-Macy's Connection | Free Lunch

2018-09-18 zacks
On today’s episode of Free Lunch, Associate Stock Strategist Ryan McQueeney recaps earnings results from Oracle and FedEx, discusses Trump’s new tariff announcement, and explains why Facebook and Macy’s have teamed up. Later, the host is joined by Dave Bartosiak to chat about Nio, the so-called Tesla of China.
ELY FB CY TXN FDX M ORCL RHT

3
Meet the New Macy’s Facebook Collaboration: Just in Time for the Holidays

2018-09-18 247wallst
Macy’s Inc. (NYSE: M) announced that it would be partnering with Facebook Inc. (NASDAQ: FB) in an effort to expand its e-commerce customer experience. The retail chain also will add other new features to its enterprise, including virtual reality and augmented reality.
FB M

14
TGT, M, GPS Ramp Up Hiring for Upcoming Holiday Season

2018-09-18 zacks
With holiday season a couple of months away, retailers are already on a hiring spree to meet the festive rush. Needless to say, competition will be stiff whether it is brick-and-mortar stores or e-commerce platforms. As the season accounts for a sizeable chunk of yearly revenues and profits, retail bellwethers will go the extra mile to woo bargain hunters be it early-hour store openings, huge discounts, promotional strategies and free shipping on online purchases.
TGT TXN DSW MDPEB ZUMZ M URBN MDP

81
10 Best High-Growth Stocks for Young Investors

2018-09-17 investorplace - 3
No investment strategy suits all the people all the time. This is particularly true for young investors in their 20s and 30s. Youth not only has social advantages; it can provide significant margin for your portfolio to grow. As such, high-growth stocks are ideal for the young-adult, millennial demographic.
SQ GE GEC MHVYF ACBFF K CTRL CVNA M CGC GLD CMG VYGR ACB AMZN KGC O87 WEED GNE TNET 7011

40
More Good News for Workers Looking for Seasonal Jobs

2018-09-17 247wallst
Last Thursday, Target Corp. (NYSE: TGT) announced plans to hire 120,000 seasonal workers to get the company through the 2018 holiday shopping season. That ties the single largest seasonal hiring plan ever announced, equal to last’s year’s total of 120,000 seasonal jobs at Amazon.com Inc. (NASDAQ: AMZN).
TGT BURL UPS AMZN BONTQ FDX M LB BONT

246
Stocks To Watch: Oracle Looks To Lift Tech Sector

2018-09-15 seekingalpha - 4
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
DOVA GIS TXN CAT AZO TWX RCL OPRF MAS HABT SHAK SUM BOX SONC RCII ABBV USCR FOX REGN BAC SQ DFS TRV COF-P WK BX JACK SYF AIG WEN ALL IDA KNSA NVS ABBV MSFT FL ZOES PFE ADS FOXA MLM JD NIO ATH DRI CX PYPL AXP MCO JBHT BRO EXP USB BAC COF-D COF-C COF-F HIG AAPL VMC TSG ORCL DEO MCD BMY RRGB WBC C CMCSA O THO MA M COF FDX NAVG HUM SNY RHT DSKE JPM IBOC MU DHR

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to M / Macy's, Inc. on message board site Silicon Investor.

A Real American President: Donald Trump A Real American President: Donald Trump A Real American President: Donald Trump The Trump Presidency The Trump Presidency The Trump Presidency
Formerly About Advanced Micro Devices Formerly About Advanced Micro Devices Formerly About Advanced Micro Devices View from the Center and Left View from the Center and Left View from the Center and Left
The Zenyatta Information Board The Zenyatta Information Board The Zenyatta Information Board Politics for Pros- moderated Politics for Pros- moderated Politics for Pros- moderated
AMD, ARMH, INTC, NVDA AMD, ARMH, INTC, NVDA AMD, ARMH, INTC, NVDA Dutch Central Bank Sale Announcement Imminent? Dutch Central Bank Sale Announcement Imminent? Dutch Central Bank Sale Announcement Imminent?
Buy and Sell Signals, and Other Market Perspectives Buy and Sell Signals, and Other Market Perspectives Buy and Sell Signals, and Other Market Perspectives Military Strategy Board Military Strategy Board Military Strategy Board
CUSIP: 55616P104